Regular follow-up appointments should be maintained to monitor weight loss progress, glycemic control (if diabetic), thyroid function, and overall tolerance of therapy
A major trial, the EMPA-REG Outcome study, Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes enrolled patients with type 2 diabetes who were also at high risk of cardiovascular events such as strokes or heart attacks to take Empagliflozin and monitor if there were any beneficial effects in this group
Nithianantharajah J, Hannan AJ
We are committed to protecting your privacy and do not share any customer data with third parties
It may also help reduce the risk of major heart-related events in certain adults with Obesity or being overweight
23 This nuanced association between smoking and premature graying underscores the multifaceted impact of environmental factors on hair health and pigmentation (Table 1)